Trial · NCT02647359
Results by group49
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 49
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Maximum Reading Speed of Oculus Unitas (OU) (Both Eyes) at Week 48, as Measured Using the Minnesota Low Vision Reading Test (MNREAD) Acuity Charts | Ataluren | 9.87 | Standard Error 7.425 | percent change | |
| Percent Change From Baseline in Maximum Reading Speed of Oculus Unitas (OU) (Both Eyes) at Week 48, as Measured Using the Minnesota Low Vision Reading Test (MNREAD) Acuity Charts | Placebo | -0.89 | Standard Error 11.809 | percent change | |
| Change From Baseline in Reading Accessibility Index of Both Eyes at Week 48 | Ataluren | 0.10 | Standard Deviation 0.241 | units on a scale | |
| Change From Baseline in Reading Accessibility Index of Both Eyes at Week 48 | Placebo | 0.02 | Standard Deviation 0.267 | units on a scale | |
| Change From Baseline in Best Corrected Visual Acuity (BCVA) at Week 48 | Ataluren | Left Eye | -0.00 | Standard Deviation 0.076 | LogMAR |
| Change From Baseline in Best Corrected Visual Acuity (BCVA) at Week 48 | Placebo | Left Eye | 0.01 | Standard Deviation 0.103 | LogMAR |
| Change From Baseline in Best Corrected Visual Acuity (BCVA) at Week 48 | Ataluren | Right Eye | 0.03 | Standard Deviation 0.125 | LogMAR |
| Change From Baseline in Best Corrected Visual Acuity (BCVA) at Week 48 | Placebo | Right Eye | -0.04 | Standard Deviation 0.138 | LogMAR |
| Percent Change From Baseline in Maximum Reading Speed of Oculus Dexter (OD) (Right Eye) and Oculus Sinister (OS) (Left Eye) at Week 48 | Ataluren | Left Eye | 8.70 | Standard Deviation 36.464 | percent change |
| Percent Change From Baseline in Maximum Reading Speed of Oculus Dexter (OD) (Right Eye) and Oculus Sinister (OS) (Left Eye) at Week 48 | Placebo | Left Eye | -4.11 | Standard Deviation 38.380 | percent change |
| Percent Change From Baseline in Maximum Reading Speed of Oculus Dexter (OD) (Right Eye) and Oculus Sinister (OS) (Left Eye) at Week 48 | Ataluren | Right Eye | 19.05 | Standard Deviation 39.116 | percent change |
| Percent Change From Baseline in Maximum Reading Speed of Oculus Dexter (OD) (Right Eye) and Oculus Sinister (OS) (Left Eye) at Week 48 | Placebo | Right Eye | -3.83 | Standard Deviation 21.091 | percent change |
| Change From Baseline in Reading Accessibility Index of Right Eye and Left Eye at Week 48 | Ataluren | Left Eye | -0.70 | Standard Deviation 2.601 | units on a scale |
| Change From Baseline in Reading Accessibility Index of Right Eye and Left Eye at Week 48 | Placebo | Left Eye | 0.01 | Standard Deviation 0.224 | units on a scale |
| Change From Baseline in Reading Accessibility Index of Right Eye and Left Eye at Week 48 | Ataluren | Right Eye | 0.04 | Standard Deviation 0.048 | units on a scale |
| Change From Baseline in Reading Accessibility Index of Right Eye and Left Eye at Week 48 | Placebo | Right Eye | 0.05 | Standard Deviation 0.128 | units on a scale |
| Change From Baseline in Critical Print Size (CPS) of Both Eyes, Right Eye, and Left Eye at Week 48 | Ataluren | Both Eyes | -0.19 | Standard Deviation 0.259 | LogMAR |
| Change From Baseline in Critical Print Size (CPS) of Both Eyes, Right Eye, and Left Eye at Week 48 | Placebo | Both Eyes | 0.12 | Standard Deviation 0.433 | LogMAR |
| Change From Baseline in Critical Print Size (CPS) of Both Eyes, Right Eye, and Left Eye at Week 48 | Ataluren | Left Eye | -0.05 | Standard Deviation 0.198 | LogMAR |
| Change From Baseline in Critical Print Size (CPS) of Both Eyes, Right Eye, and Left Eye at Week 48 | Placebo | Left Eye | 0.07 | Standard Deviation 0.271 | LogMAR |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02647359/results